# NCT03599765 (NCT03599765)

> Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03599765
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Oligometastatic Malignant Solid Neoplasm
- Interventions: Best Practice; Local Consolidation Therapy
- Enrollment: 380
- Primary outcome: Incidence of adverse events
- Primary outcome: Progression free survival
- Primary outcome: Time to development of new distant metastases
- Primary outcome: Overall survival

## Indexed commentary on NCT03599765 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct03599765